We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
10 Year Est. Return
AUM
$166M
AUM Growth
+$16M
Cap. Flow
+$1.45M
Cap. Flow %
0.88%
Top 10 Hldgs %
55.72%
Holding
118
New
10
Increased
50
Reduced
38
Closed
6

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$346K
2
HOOD icon
Robinhood
HOOD
+$322K
3
RDDT icon
Reddit
RDDT
+$320K
4
AAPL icon
Apple
AAPL
+$285K
5
COIN icon
Coinbase
COIN
+$263K

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$1.41M
2
ANET icon
Arista Networks
ANET
+$285K
3
DHR icon
Danaher
DHR
+$223K
4
LULU icon
lululemon athletica
LULU
+$214K
5
SYK icon
Stryker
SYK
+$207K

Sector Composition

Rank Sector Weight
1 Technology 63.9%
2 Healthcare 8.46%
3 Financials 7.13%
4 Communication Services 5.84%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
51
Parker-Hannifin
PH
$135B
$718K 0.43%
946
-5
-0.5% -$3.69K
ISRG icon
52
Intuitive Surgical
ISRG
$132B
$679K 0.41%
1,519
+19
+1% +$9.12K
TSM icon
53
TSMC
TSM
$2.17T
$650K 0.39%
2,328
-5
-0.2% -$1.22K
MCD icon
54
McDonald's
MCD
$196B
$649K 0.39%
2,135
-8
-0.4% -$2.44K
IVW icon
55
iShares S&P 500 Growth ETF
IVW
$77B
$630K 0.38%
5,222
VRTX icon
56
Vertex Pharmaceuticals
VRTX
$123B
$616K 0.37%
1,572
-50
-3% -$20.9K
BRK.B icon
57
Berkshire Hathaway Class B
BRK.B
$1.13T
$615K 0.37%
1,224
-76
-6% -$36.8K
NXPI icon
58
NXP Semiconductors
NXPI
$58.4B
$603K 0.36%
2,646
-65
-2% -$14.6K
TMO icon
59
Thermo Fisher Scientific
TMO
$214B
$593K 0.36%
1,223
-64
-5% -$29.8K
IBM icon
60
IBM
IBM
$220B
$593K 0.36%
2,101
+131
+7% +$34.3K
ONON icon
61
On Holding
ONON
$12.4B
$573K 0.35%
13,525
-35
-0.3% -$1.67K
DELL icon
62
Dell
DELL
$283B
$554K 0.33%
3,905
-116
-3% -$15.1K
BMY icon
63
Bristol-Myers Squibb
BMY
$131B
$531K 0.32%
11,764
-2,017
-15% -$94.2K
PAYX icon
64
Paychex
PAYX
$42.7B
$528K 0.32%
4,168
-50
-1% -$6.94K
SCHW
65
Charles Schwab
SCHW
$187B
$523K 0.32%
5,481
+3
+0.1% +$285
IWM icon
66
iShares Russell 2000 ETF
IWM
$82.1B
$505K 0.31%
2,088
-19
-0.9% -$4.36K
TWLO icon
67
Twilio
TWLO
$29.3B
$482K 0.29%
4,820
TXN icon
68
Texas Instruments
TXN
$254B
$479K 0.29%
2,608
+150
+6% +$29.3K
MAS icon
69
Masco
MAS
$14.9B
$452K 0.27%
6,419
-96
-1% -$6.76K
HOOD icon
70
Robinhood
HOOD
$81.6B
$423K 0.26%
+2,953
New +$322K
XYZ
71
Block Inc
XYZ
$47B
$416K 0.25%
5,760
+310
+6% +$23.2K
KMI icon
72
Kinder Morgan
KMI
$69.7B
$413K 0.25%
14,593
+170
+1% +$4.65K
CEG icon
73
Constellation Energy
CEG
$93.2B
$405K 0.24%
1,232
+106
+9% +$34.2K
UNH icon
74
UnitedHealth
UNH
$367B
$395K 0.24%
+1,143
New +$346K
VOO icon
75
Vanguard S&P 500 ETF
VOO
$1.01T
$379K 0.23%
618

Similar funds

KRS Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, KRS Capital Management held 118 positions worth $166M, up 11% from $150M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

KRS Capital Management's Q3 2025 filing shows 10 new, 50 increased, 38 reduced and 6 closed positions. Its largest new stake was UnitedHealth: 1,143 shares worth $395K. The largest sale was Lam Research, an estimated $1.41M.

By sector, the portfolio is most concentrated in Technology at 64% of assets, up from 63% a quarter earlier, followed by Healthcare and Financials.

  • KRS Capital Management's largest Q3 2025 buy was UnitedHealth: 1,143 shares worth $395K.
  • KRS Capital Management added most to Apple in Q3 2025, an estimated $285K increase.
  • KRS Capital Management's biggest Q3 2025 reduction was Bristol-Myers Squibb, cutting an estimated $94.2K.
  • KRS Capital Management fully exited Lam Research in Q3 2025, selling an estimated $1.41M.
  • KRS Capital Management's ten largest holdings make up 56% of its $166M portfolio in Q3 2025.
  • KRS Capital Management opened 10 new positions and closed 6 in Q3 2025.
  • KRS Capital Management's portfolio value rose 11% quarter-over-quarter to $166M.

Based on KRS Capital Management's 13F filing for Q3 2025, filed 16 Oct 2025.